Inovio Pharmaceuticals Inc vs Star Bulk Carriers Corp — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Star Bulk Carriers Corp trades at $26.63 (market cap $2.91B). The key difference: Star Bulk Carriers Corp is far larger — about 32.6× Inovio Pharmaceuticals Inc's market cap, and Star Bulk Carriers Corp pays a 3.95% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | SBLK | |
|---|---|---|
Market Cap | $89.27M | $2.91B |
Sector | Health | Industrials |
52-Week High | $2.87 | $28.21 |
52-Week Low | $1.05 | $16.79 |
Enterprise Value | $60.28M | $3.61B |
Dividend Yield | — | 3.95% |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →